Provista Diagnostics

Provista Diagnostics is a company based in Alpharetta, Georgia, specializing in the development and provision of diagnostic solutions. As a smaller company with 10 employees, Provista Diagnostics generated $5.7 million in revenue. Provista Diagnostics focuses on creating empowering diagnostics for Women's Health, aiming to assist both patients and clinicians in making more informed decisions regarding health and quality of life. Their current offerings include COVID-19 PCR testing, with a portion of the profits from this service being reinvested into the development of life-saving diagnostic solutions for various health conditions. One of Provista Diagnostics' key differentiators is its commitment to investing in the future of diagnostics. They are actively developing innovative solutions, with Videssa Breast Cancer Detection set to launch in the fourth quarter of 2022. This product highlights their dedication to improving healthcare through early detection and intervention. For more information about Provista Diagnostics and their services, please visit their website at provistadx.com.